What's Left in Cassava After Phase 3 Setback for Alzheimer's Drug

Seeking Alpha11:17 ET

Express News | Cassava Sciences Shares Fall 4% After 84% Slump in Previous Session

ReutersNov 26 09:40 ET

Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)

Zacks Nov 26 08:40 ET

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

BenzingaNov 26 08:13 ET

Cassava Sciences Cut to Neutral From Buy by HC Wainwright & Co.

Dow JonesNov 26 07:07 ET · Ratings

Cassava Sciences Price Target Announced at $116.00/Share by HC Wainwright & Co.

Dow JonesNov 26 07:07 ET · Ratings